LAUSR

1 Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306. 2 Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508–512. 3 Berman H, Rodr ıguez-Pint o I, Cervera R, et al.; Catastrophic Registry Project Group (European Forum on Antiphospholipid Antibodies). Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the “CAPS Registry”. Autoimmun Rev 2014; 13: 157–162. 4 Go EJL, O’Neil KM. The catastrophic antiphospholipid syndrome in children. Curr Opin Rheumatol 2017; 29: 516–522. 5 Cervera R, Rodr ıguez-Pint o I, Espinosa G. The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review. J Autoimmun 2018; 92: 1–11.